 |
Tipifarnib |
|---|---|
| Trade Name | Zarnestra |
| Orphan Indication | Acute myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2004-07-06 00:00:00 |
| Sponsor | Johnson & Johnson Pharmaceutical Research & Dev.;920 U.S. Highway 202;Raritan, New Jersey, 08869 |
| |
Tipifarnib |
|---|---|
| Trade Name | Zarnestra |
| Orphan Indication | Acute myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2004-07-06 00:00:00 |
| Sponsor | Johnson & Johnson Pharmaceutical Research & Dev.;920 U.S. Highway 202;Raritan, New Jersey, 08869 |